FDA Investigator Kellie L Westerbuhr

Kellie L Westerbuhr has conducted inspections on 291 sites in 3 countries as of 11 Aug 2014. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
291
Last Inspection Date:
11 Aug 2014
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Canada, China
FDA Investigators that have inspected at least one site in common with Kellie L Westerbuhr:
Aaron L Dunbar, Adam J Taylor, Ahmad R Mcgowan, Aimee J Edwin, Alan R Albrecht, Albert L Nguyen, Alexander M Kay, Alfred P Pistorio, Alison A Nicoli, Althea A Williams, Amanda B Athey, Amy F Anderson, Amy L Mcintyre, Ana M Placencia, Anthony J Ladner, Anthony L Nicoli, April L Brown, April L Young, Ashley M Whitehurst, Aswin T Subketkaew, Benjamin W Anderson, Billi Jom Johnson, Boun M Xiong, Bradley A Servais, Brandon L Mariner, Brent T Hall, Brian E Thompson, Carolyn A Warren, Catherine M Vanderhoef, Charles R Cote, RIC, Cheryl A Clausen, Christina A Castineyra, Christina L Bigham, Christine M Erickson, Cordelia J Brammer, Courtney R Ingalsbe, Courtney R Tiegs, Craig R Berger, Dacia E Quick, Dale A Nyberg, Darlene L Krieger, Darren D Holaday, David B Wieneke, David J Ward, Dayle Radde, Debra D Devlieger, Demetria L Lueneburg, Denise L Burosh, Dianna C Sonnenburg, Dolores E Price, Doretha M Tonkins, Doretha M Wilson, Douglas J Snyder, Douglas W Atkins, Duc Minh H Nguyen, Edward A Fabiano, Edward M James, Elizabeth E Hart (ASCP), MT, Elizabeth P Mayer, Ellen C Weisensel, Emily E Markgraf, Eric M Padgett, Eric S Myskowski, Eric T Huebler, Erin Norling, Fannie M Harrell, Frank S Sedzielarz, Garrett W Steiner, Gina M Scholze, Grant M Ruis, Gregory S Larson, Gregory W Smith, Heather Akleimola Hulbert, Heidi J Debeck, Howard A Burmester, Ivan E Reyes, Jaclyn N Munsch, Jake T Lane, James A Beaulieu, James K Ireland, Jane E Nelson, Janis R Armedoriz, Jean M Trimbo, Jeffery A Hangartner, Jennifer A Jones, Jennifer A Longie Vollom, Jennifer Al Vollon, Jennifer L Custodio, Jennifer R Mathern, Jennifer S Ness, Jeremy L Tri, Jesse P Romenesko, Jessica L Barr, Jessica L Johnson, Jessica M Novak, Jocelyn M Muggli, Joel D Hustedt, Joey C West, John A Iwen, John E Emmert, John P Hermann, John T Quaife, Jon C Polzine, Jonathan L Blonk, Joseph D Gong, Joseph J Golden, Joseph M Edwin, Judy Ellen Ciaraldi, Julie Woodberry, Karen M Jirele, Karen M Labounty, Karla J Youngberg, Katherine A Clarke Girolamo, Keith C Rindahl, Kellie L Thommes, RN, Kenneth A Libertoski, Kenneth L Smalls, Kevin L Torgerson, Kibily D Dembele, Kip J Hanks, Krista K Petersen, Kristy E Zuroski, Kyle J Mccracken, La Tasham Gunter, Laiza V Garcia, Larae M Koopman, Lauren E Sanger, Lauren E Swantko, Lauren M Lilly, PhD, LCDR Ismael Olvera, IV, Leonardm, Linda S Mattingly, Linda V Weyer, Mada A Tautges, Margaret L Bolte, Margaret M Lubbers Solberg, Maria E Treadwell, Marie A Fadden, Marion Hinnenkamp, Marissa S Henning, Marissa S Steinhagen, Mark W Babbitt, Marla A Cassidy, Mary A Millner, Mary M Finn, Maryann Ruff, Matthew B Casale, Melanie C Voges, Melissa D Kalik, Melissa I Michurski, Melissa J Holz, Michael A Blaine, Michael E Cimaglio, Michael Smith, Michael T Nehring, Michelle J Glembin, Miles D Foster, Mohammed H Adam, Nancy L Meade, Nancy L Neiger, Nicholas R Nance, Nicole C Victoria, PhD, Nina D Patel, Paola E Lathrop, Patricia A Holmstrom, Patricia A Morrow, Patrick J Campbell, Ralph Jerndal, Randy L Clarida, Rebecca L Caulfield, Rebecca L Keller, Rhonda L Mecl, Richard J Bashay, Robert H Claflin, Robert J Waldorf, Robert M Tillman, Ross J Grigsby, Rostislav Servetnyk, Ryan J Benedict, Sana A Elassar, Sandra Sejdinovic, Sarah A Palmer, Scott A Golladay, Scott L Schenian, Seth A Abbott, Sharon K Thoma, PharmD, Sharon L Matson, Sharon M Harold, Shaun M Olson, Shavon L Square, Stacie Schanus, Stephanie Mangigian, MS/OSH, RN, Steven A Skaar, Steven J Crowston, Susan M Atcher, Susan M Matthias, Susan M Miller, Susan M North, Tamika E Allen, RN, Tara C Singh, Terrance L Scheiber, Theresa C Klaman, Thomas S Donaldson, Tiffany P Kelley, Timothy G Philips, Timothy R Marrs, Tony T Yang, Traci C Kelm, Tracy A Solseng, Travis S Bradley, Troy A Brenny, Tyler R Courtney, Ulysses D Singleton, Verdell Nelson, Victoria L Palmer, Wayne W Grundstrom, Wendy L Trefethren Grang, William P Fournier, Yehualashet A Gessesse, Zachary P Wachlarowicz

Kellie L Westerbuhr's Documents

Publish Date Document Type Title
April, 2009 FDA 483 Innovative Blood Resources - Form 483, 2009-04-21
August, 2010 FDA 483 University of Minnesota Medical Center, Fairview - Form 483, 2010-08-25
February, 2005 EIR WuXi AppTec Inc. - EIR, 2005-02-08
July, 2003 EIR Infinity Transplant Services, Inc - EIR, 2003-07-30
September, 2010 EIR WuXi AppTec Inc. - EIR, 2010-09-07
December, 2006 FDA 483 South Dakota Lions Eye Bank, Inc. - Form 483, 2006-12-04
July, 2013 FDA 483 University of Minnesota Medical Center, Fairview - Form 483, 2013-07-30
September, 2003 EIR Avera McKennan Hospital & University Health Center - EIR, 2003-09-10
July, 2013 EIR University of Minnesota Medical Center, Fairview - EIR, 2013-07-30
January, 2012 EIR LifeSource-Upper Midwest OPO - EIR, 2012-01-24
July, 2003 FDA 483 Innovative Blood Resources - Form 483, 2003-07-24
December, 2003 EIR American Medical Systems, LLC - EIR, 2003-12-11
July, 2003 EIR Innovative Blood Resources - EIR, 2003-07-24
January, 2012 FDA 483 LifeSource-Upper Midwest OPO - Form 483, 2012-01-24
December, 2003 FDA 483 American Medical Systems, LLC - Form 483, 2003-12-11
March, 2004 FDA 483 WuXi AppTec Inc. - Form 483, 2004-03-04
June, 2006 FDA 483 Medtronic Neuromodulation - Form 483, 2006-06-22
August, 2010 EIR University of Minnesota Medical Center, Fairview - EIR, 2010-08-25
January, 2004 EIR Team Spine Minnesota, Inc - EIR, 2004-01-26
September, 2013 FDA 483 Steris Laboratories - Form 483, 2013-09-13
March, 2004 FDA 483 Response WuXi AppTec Inc. - Form 483R, 2004-04-06
March, 2004 EIR Innovative Blood Resources - EIR, 2004-03-22
March, 2003 EIR Laboratory Corporation of America ViroMed Laboratories - EIR, 2003-03-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more